抄録
Many pharmacological treatments for Alzheimer disease (AD) exist, including treatment with reversible cholinesterase inhibitors which has improved cognition and slowed progression of dementia in some patients, as low levels of acetylcholine are regarded as one of the potential causes of this disease. High levels of the β-amyloids are regarded as another possible contributing factor. Laser therapy and magnetic field therapy have shown promise, singly and, much better, together in reversing these two potential AD-related conditions. The present study examined polylaser therapy on its own and combined with magnetic field therapy in 42 patients diagnosed as having AD, in whom the activity of cholinesterase in the blood significantly decreased compared with the initial levels, and simultaneously the concentration of acetylcholine and cholinergic index were enhanced. A noticeable effect was achieved in more than half the time in the patients treated with the combination therapy, compared with polylaser alone. A control group of 22 non-dementia patients with familial mediterranean fever (FMF) complicated with amyloidosis were treated with polylaser together with plant-derived medicines (phytoceuticals), to assess the potential effects of this regimen on the amyloidosis component of FMF. In the 18 patients with grade I-II FMF, complete regression of the amyloidosis, proteinuria and improvement of kidney function were achieved. In the remaining 4 patients, grades IIa-III, no such improvement was detected. Combined therapy with polylaser and magnetic field energy coupled with the use of appropriate phytoceuticals my well offer an interesting ine of approach in the treatment of ADE, in addition to helping solve the problem of finding a successful treatment of FMF
